Medical Professionals > Research > Clinical Trials
Clinical Trials
NSABP B-40
| |
| Cancer Type: Breast |
Description: A Randomized Phase III Trial of Neoadjuvant Therapy in Patients with Palpable and Operable Breast Cancer Evaluating the Effect on Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine to Docetaxel when Administered Before AC with or without Bevacizumab and Correlative Science Studies Attempting to Identify Predictors of High Likelihood for pCR with Each of the Regimens
|
Entity Approving The Trial:
National Surgical Adjuvant Breast and Bowel Project (NSABP) |
| Phase: III |
| Site-Wide Accrual Goal: 1,200 |
| |
| No related files found. |
| |
| http://www.cancer.gov/search/viewclinicaltrials.aspx?version=healthprofessional&cdrid=515432 |
